CDS22-formula at BSG LIVE'26 in Liverpool: Supporting Clinicians and Patients Across the UK and Ireland
CDS22-formula, the original De Simone Formulation, was exhibited at BSG LIVE'26, the British Society of Gastroenterology's annual congress in Liverpool. This is a short factual update on the event and what was shared with the gastroenterology professionals who visited the stand.
CDS22-formula, the original De Simone Formulation (8 strains, 450 billion CFU per sachet), was exhibited at BSG LIVE'26, the British Society of Gastroenterology's annual congress, held at ACC Liverpool from 22 to 25 June 2026. The stand was a joint presence by Probiotic.co.uk, the authorised UK distributor, and CDS22-formula the manufacturer of the formulation. Over four days, the team provided scientific literature on the De Simone Formulation and product samples to gastroenterologists, nurses, pharmacists, and other healthcare professionals. CDS22-formula is a food supplement regulated by the Food Standards Agency (FSA) in the UK, not a medicine, and is not intended to diagnose, treat, cure, or prevent any disease. It is available across the UK from Probiotic.co.uk and in Ireland from Probiotic.ie, from £19.95 for the 450 billion CFU sachet 12-pack.
CDS22-formula definition: CDS22-formula is the original 8-strain, 450 billion CFU probiotic mixture developed by Professor Claudio De Simone (the "De Simone Formulation"), sold under the VSL#3* brand until 2016 and later as Vivomixx*, and now supplied in the UK as CDS22-formula.
*Previously marketed as Vivomixx* (owned by Mendes SA) until 2025 and VSL#3* (owned by Actial Srl) prior to that. No affiliation to these brands exists.
BSG LIVE'26 in brief: the annual congress of the British Society of Gastroenterology, held at ACC Liverpool from 22 to 25 June 2026, bringing together physicians, surgeons, nurses, dietitians, and other professionals working in gastroenterology and hepatology.
CDS22-formula at BSG LIVE'26 in Liverpool
CDS22-formula was exhibited at BSG LIVE'26, held at ACC Liverpool from 22 to 25 June 2026. The stand was a collaborative one, run by Probiotic.co.uk, the authorised UK distributor of CDS22-formula, alongside the manufacturer of the formulation itself.
CDS22-formula is the current name for the original De Simone Formulation, an 8-strain probiotic mixture developed by Professor Claudio De Simone. The same formulation was previously sold as VSL#3* until 2016 and as Vivomixx* until 2025. Exhibiting at a congress of this scale, in our second year doing so and around 18 months into the UK market, reflects the formulation's standing as a long-studied high-potency probiotic.
It is worth being clear on one point: exhibiting at BSG LIVE is not an endorsement by the British Society of Gastroenterology. The congress states that sponsors and exhibitors have no input into its scientific agenda. Our purpose at the stand was to provide information and product access to the healthcare professionals who chose to visit.
About BSG LIVE'26 and the British Society of Gastroenterology
The British Society of Gastroenterology (BSG) is a UK organisation focused on gastroenterology and hepatology, with over 4,000 members drawn from physicians, surgeons, pathologists, radiologists, scientists, nurses, dietitians, and others working in the field.
BSG LIVE'26 ran under the theme "Transforming Care Through Precision and Personalised Medicine" and covered the full breadth of the speciality through symposia, plenary sessions, an industry exhibition, and a scientific poster gallery. For a UK distributor of a clinical-grade probiotic, it is the single most relevant professional gathering in the calendar.
What we shared at the stand
Across all four days the team focused on the frontline professionals who support people with digestive conditions: gastroenterologists, specialist nurses, pharmacists, and doctors. The stand offered two things.
First, scientific literature on CDS22-formula and the De Simone Formulation, drawn from the published research base on the formulation. Second, product samples of both the 450 billion CFU sachets and the 112 billion CFU capsules.
CDS22-formula was among a small number of clinical-grade, high-potency probiotic formulations represented at the exhibition, with Probiotic.co.uk attending as its authorised UK distributor.
CDS22-formula availability in the UK and Ireland
Probiotic.co.uk is the authorised UK distributor of CDS22-formula, with tracked delivery across the UK including Northern Ireland. In Ireland, the formulation is supplied through Probiotic.ie.
The range covers the 450 billion CFU sachets for higher-strength use and the 112 billion CFU capsules for daily support. Full strain detail, the 2016 brand-split timeline, and the ECCO clarification are set out in our De Simone Formulation UK reference guide.
Clinician, pharmacy, and further reading
Healthcare professionals and pharmacies who spoke with us at BSG LIVE'26, or who would like the same information, can access the following:
The published research library for the De Simone Formulation for the underlying evidence base. The CDS22 delivery information page for handling and logistics detail. The CDS22 wholesale and pharmacy portal for trade and clinic supply. Distribution documentation is available on request for verification purposes.
- CDS22-formula is the current name for the original De Simone Formulation, an 8-strain probiotic mixture developed by Professor Claudio De Simone.
- BSG LIVE'26 was held at ACC Liverpool from 22 to 25 June 2026, the annual congress of the British Society of Gastroenterology.
- The stand was a joint presence by Probiotic.co.uk, the authorised UK distributor, and the manufacturer of the formulation.
- The team provided scientific literature and product samples to gastroenterologists, nurses, pharmacists, and doctors over four days.
- Exhibiting at BSG LIVE is not an endorsement by the British Society of Gastroenterology; exhibitors have no input into the scientific agenda.
- CDS22-formula is a food supplement regulated by the FSA in the UK, not a medicine.
- The 450 billion CFU sachet 12-pack is available from £19.95, with tracked UK delivery, and via Probiotic.ie in Ireland.
The published research discussed relates to the De Simone Formulation as a studied compound. It should not be read as a claim that CDS22-formula produces any specific health effect. CDS22-formula is a food supplement, not a medicine. No authorised health claim is made for it on this page or on the product.
CDS22-formula — the original De Simone Formulation
8 strains, 450 billion CFU per sachet. Tracked delivery across the UK and Ireland.
Food supplement, not a medicine. Prices include UK VAT at 20%. From £19.95.
Frequently asked questions
Was CDS22-formula at BSG LIVE 2026?
Yes. CDS22-formula, the original De Simone Formulation (8 strains, 450 billion CFU), was exhibited at BSG LIVE'26, the British Society of Gastroenterology's annual congress, held at ACC Liverpool from 22 to 25 June 2026. The stand was run by Probiotic.co.uk, the authorised UK distributor of CDS22-formula, alongside the manufacturer of the formulation.
What is BSG LIVE?
BSG LIVE is the annual congress of the British Society of Gastroenterology, a UK organisation with over 4,000 members including physicians, surgeons, pathologists, nurses, and dietitians working in gastroenterology and hepatology. BSG LIVE'26 was held at ACC Liverpool from 22 to 25 June 2026.
Is CDS22-formula a medicine?
No. CDS22-formula is a food supplement regulated in the UK under Food Standards Agency (FSA) guidelines and is not a medicine. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition.
Where can I buy CDS22-formula in the UK and Ireland?
CDS22-formula is available in the UK from Probiotic.co.uk, the authorised UK distributor, with tracked delivery across the UK. It is available in Ireland from Probiotic.ie. The 450 billion CFU sachet 12-pack is priced from £19.95 in the UK.
This update is for general information only and does not constitute medical advice. CDS22-formula is a food supplement regulated under FSA guidelines and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. The NHS recommends seeing a GP if digestive symptoms persist for more than three weeks. Probiotic.co.uk is regulated under UK food supplement legislation.
- BSG LIVE'26, British Society of Gastroenterology annual congress, ACC Liverpool, 22 to 25 June 2026. — live.bsg.org.uk
- British Society of Gastroenterology. — bsg.org.uk
- Food Standards Agency. Food supplements business guidance. — food.gov.uk
- De Simone Formulation UK reference: legal timeline, strains, availability. Probiotic.co.uk. — probiotic.co.uk